Medicure Inc (TSXV:MPH)(OTC:MCUJF), a pharmaceutical company, announced yesterday its financial results for the quarter ended 30 June 2019.
The company reported adjusted EBITDA for the quarter ended 30 June 2019 at USD103,000 compared to adjusted EBITDA of USD882,000 for the quarter ended 30 June 2018.
The firm posted net loss for the quarter ended 30 June 2019 at USD957,000 compared to net income of USD1.6m for the quarter ended 30 June 2018.
Net loss for the six months ended 30 June 2019 was USD3.7m or USD0.24 per share. This compares to net income of USD3.0m or USD0.19 per share for the six months ended 30 June 2018.
AbbVie Inc announces quarterly cash dividend
AstraZeneca to supply 400m doses of COVID-19 vaccine
Poxel Successfully Raises EUR 17.7m in a Capital Increase
Merck to pay USD0.61 per share dividend in Q3 2020
Bactiguard swings to profit in Q1 2020; Positive effect of COVID-19 pandemic on sales and earnings
Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum Haemorrhage in All Births
Mylan collaborates with Gilead Sciences for remdesivir distribution
Mylan to distribute investigational antiviral remdesivir for the potential treatment of COVID-19